Iris Unina Prodmetadata only
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?
cell engineering, drug evaluation, preclinical, immunotherapy, adoptive, receptors, chimeric antigen, t-lymphocytes
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 235408
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.